Trends In The Availability Of Buprenorphine At US Retail Pharmacies, 2017–23
Health Affairs · 2025
DOI: 10.1377/hlthaff.2025.00349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs, 2025. Verfasst von Jenny S Guadamuz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jenny S. Guadamuz, University of California Berkeley, Berkeley, California. Hauptthemen laut MEDLINE: Buprenorphine, Pharmacies, Opioid-Related Disorders, Health Services Accessibility. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
From 2017 to 2023, the percentage of US pharmacies regularly dispensing buprenorphine increased from 33 percent to 39 percent. Buprenorphine availability varied substantially across states, counties, and neighborhoods, with pharmacies in low-income, Black, or Latinx neighborhoods persistently less likely to regularly dispense buprenorphine than pharmacies in other neighborhoods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jenny S. Guadamuz, University of California Berkeley, Berkeley, California.
- Sarah Axeen, University of Southern California, Los Angeles, California.
- Dima Mazen Qato (qato@usc.edu), University of Southern California.
Zitieren
APA
Guadamuz, J. S., Axeen, S., & Qato, D. M. (2025). Trends In The Availability Of Buprenorphine At US Retail Pharmacies, 2017–23. Health Affairs. https://doi.org/10.1377/hlthaff.2025.00349
Vancouver
Guadamuz JS, Axeen S, Qato DM. Trends In The Availability Of Buprenorphine At US Retail Pharmacies, 2017–23. Health Affairs. 2025. doi:10.1377/hlthaff.2025.00349
BibTeX
@article{Guadamuz2025,
author = {Guadamuz, Jenny S and Axeen, Sarah and Qato, Dima Mazen},
title = {Trends In The Availability Of Buprenorphine At US Retail Pharmacies, 2017–23},
journal = {Health Affairs},
year = {2025},
doi = {10.1377/hlthaff.2025.00349}
}
EUVIMED